Factbox: Pending mergers and acquisitions involving U.S. firms that need Chinese approval
NEW YORK (Reuters) - U.S.
NEW YORK (Reuters) - U.S. President Donald Trump said on Friday he has ordered American companies to exit China after Beijing unveiled retaliatory tariffs on $75 billion worth of U.S. goods, in a new twist in the bitter trade war between the world's two largest economies.
Trump gave no detail on how he might proceed with his order, as he cannot legally compel U.S. companies to abandon China immediately. He said he would be offering a response to Beijing's move later on Friday.
Below are mergers and acquisitions between U.S. and international companies that have been announced and are waiting for regulatory approval from China's State Administration for Market Regulation in order to close, because they have significant operations in China.
Nvidia/Mellanox - In March, U.S. chip supplier Nvidia Corp
Merck/Versum - In April, Merck KGaA
AbbVie/Allergan - Drugmaker AbbVie Inc
Infineon/Cypress - Germany's Infineon
II-VI/Finisar - Laser and optical parts maker II-VI Inc
(Reporting by Greg Roumeliotis; Editing by Sonya Hepinstall)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
SHANGHAI (Reuters) - Tesla is planning to export Model 3 vehicles made in China to Asian and European markets, two sources familiar with the matter told Reuters on Friday. The U.S.
By Lucia Mutikani WASHINGTON (Reuters) - U.S. consumer prices rose solidly in August, with the cost of used cars and trucks accelerating by the most in more than 51 years likely as Americans shunned public transportation because of fears of contracting COVID-19
By Tanishaa Nadkar and Pushkala Aripaka (Reuters) - Life and general insurer Aviva is offloading its Singapore business to a consortium led by Singapore Life, for S$2.7 billion ($1.98 billion), as the London-listed firm sharpens its focus on Britain, Ireland and Canada.